Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence
Pier Paolo Scaglioni1, Andrea Rabellino, Thomas M Yung
1Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. pier.scaglioni@utsouthwestern.edu
Abstract:
Expression of oncogenic K-RAS in primary cells elicits oncogene-induced cellular senescence (OIS), a form of growth arrest that potently opposes tumourigenesis. This effect has been largely attributed to transcriptional mechanisms that depend on the p53 tumour suppressor protein. The PML tumour suppressor was initially identified as a component of the PML-RARα oncoprotein of acute promyelocytic leukaemia (APL). PML, a critical OIS mediator, is upregulated by oncogenic K-RAS in vivo and in vitro. We demonstrate here that oncogenic K-RAS induces PML protein upregulation by activating the RAS/MEK1/mTOR/eIF4E pathway even in the absence of p53. Under these circumstances, PML mRNA is selectively associated to polysomes. Importantly, we find that the PML 5' untranslated mRNA region plays a key role in mediating PML protein upregulation and that its presence is essential for an efficient OIS response. These findings demonstrate that upregulation of PML translation plays a central role in oncogenic K-RAS-induced OIS. Thus, selective translation initiation plays a critical role in tumour suppression with important therapeutic implications for the treatment of solid tumours and APL.
Insights
Oncogenic K-RAS triggers cellular senescence by increasing PML protein, even without p53. This process relies on enhanced PML translation, crucial for tumor suppression and offering new therapeutic avenues for cancers like APL.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Oncogene-induced cellular senescence (OIS) is a tumor suppression mechanism.
- OIS is often linked to transcriptional changes and the p53 tumor suppressor.
- PML (Promyelocytic Leukemia) protein is a known OIS mediator and tumor suppressor.
Purpose of the Study:
- To investigate the role of PML protein upregulation in oncogenic K-RAS-induced OIS.
- To elucidate the molecular mechanisms driving PML upregulation by oncogenic K-RAS, particularly in a p53-independent manner.
- To determine the significance of PML mRNA translation in OIS and tumor suppression.
Main Methods:
- Utilized primary cell cultures expressing oncogenic K-RAS.
- Analyzed PML protein and mRNA levels under oncogenic stress.
- Investigated the RAS/MEK1/mTOR/eIF4E signaling pathway.
- Examined PML mRNA association with polysomes.
- Assessed the role of the PML 5' untranslated region in translation and OIS.
Main Results:
- Oncogenic K-RAS induces PML protein upregulation via the RAS/MEK1/mTOR/eIF4E pathway, independent of p53.
- PML mRNA selectively associates with polysomes, indicating translational control.
- The 5' untranslated region of PML mRNA is essential for its upregulation and efficient OIS.
- PML translation upregulation is a key mechanism in K-RAS-driven OIS.
Conclusions:
- Translational control of PML is a critical mechanism in oncogene-induced cellular senescence.
- Selective translation initiation of PML plays a significant role in tumor suppression.
- Targeting PML translation offers potential therapeutic strategies for solid tumors and acute promyelocytic leukemia (APL).
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Replicative Cell Senescence


